Your browser doesn't support javascript.
loading
Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
Balakrishnan, Bijina; An, Ding; Nguyen, Vi; DeAntonis, Christine; Martini, Paolo G V; Lai, Kent.
Affiliation
  • Balakrishnan B; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT 84108, USA.
  • An D; Moderna, Inc., Cambridge, MA 02139, USA.
  • Nguyen V; Moderna, Inc., Cambridge, MA 02139, USA.
  • DeAntonis C; Moderna, Inc., Cambridge, MA 02139, USA.
  • Martini PGV; Moderna, Inc., Cambridge, MA 02139, USA. Electronic address: paolo.martini@modernatx.com.
  • Lai K; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT 84108, USA. Electronic address: kent.lai@hsc.utah.edu.
Mol Ther ; 28(1): 304-312, 2020 01 08.
Article in En | MEDLINE | ID: mdl-31604675

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: UTP-Hexose-1-Phosphate Uridylyltransferase / RNA, Messenger / Disease Models, Animal / Galactose / Galactosemias Type of study: Diagnostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: UTP-Hexose-1-Phosphate Uridylyltransferase / RNA, Messenger / Disease Models, Animal / Galactose / Galactosemias Type of study: Diagnostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2020 Type: Article Affiliation country: United States